Ra Medical Systems, Inc. (RMED) Financials

AMEX Currency in USD Disclaimer

$0.31

north_east NA Past Year
Day's range
$0.3
Day's range
$0.34
$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60MEarning201620162017201720182018201920192020202020212021202220220%0%-50000%-50000%-100000%-100000%-150000%-150000%-200000%-200000%Profit Margin
Profit Margin
Revenue
Earnings

RMED Income statement / Annual

Last year (2022), Ra Medical Systems, Inc.'s total revenue was $14,000.00, a decrease of 36.36% from the previous year. In 2022, Ra Medical Systems, Inc.'s net income was -$26.87 M. See Ra Medical Systems, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $14,000.00 $22,000.00 $4.41 M $7.20 M $6.26 M $5.87 M $5.98 M
Cost of Revenue $161,000.00 $1.56 M $5.48 M $8.85 M $4.21 M $4.17 M $3.14 M
Gross Profit -$147,000.00 -$1.54 M -$1.08 M -$1.65 M $2.05 M $1.71 M $2.84 M
Gross Profit Ratio -10.5 -69.91 -0.24 -0.23 0.33 0.29 0.47
Research and Development Expenses $6.39 M $12.25 M $9.01 M $4.53 M $2.78 M $4.52 M $1.72 M
General & Administrative Expenses $2.23 M $0.00 $0.00 $0.00 $30.44 M $0.00 $0.00
Selling & Marketing Expenses $1.25 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $16.25 M $15.48 M $25.97 M $51.55 M $30.44 M $14.95 M $5.32 M
Other Expenses $99,000.00 $2.01 M $21,000.00 $788,000.00 $338,000.00 $0.00 $0.00
Operating Expenses $22.64 M $27.73 M $34.98 M $56.08 M $33.21 M $19.47 M $7.04 M
Cost And Expenses $22.80 M $29.29 M $40.46 M $64.93 M $37.42 M $23.63 M $10.17 M
Interest Income $0.00 $0.00 $129,000.00 $1.04 M $352,000.00 $0.00 $0.00
Interest Expense $3.08 M $0.00 $108,000.00 $250,000.00 $14,000.00 $4,000.00 $3,000.00
Depreciation & Amortization $8.77 M $1.57 M $2.37 M $1.75 M $624,000.00 $218,000.00 $95,000.00
EBITDA -$18.20 M -$29.27 M -$36.06 M -$57.73 M -$31.16 M -$17.54 M -$4.10 M
EBITDA Ratio -1299.71 -1330.27 -8.19 -8.02 -4.98 -2.99 -0.69
Operating Income Ratio -1925.79 -1330.27 -8.19 -8.02 -4.98 -3.03 -0.7
Total Other Income/Expenses Net $3,000.00 $2.01 M $21,000.00 $788,000.00 $338,000.00 -$4,000.00 -$3,000.00
Income Before Tax -$26.86 M -$27.26 M -$36.04 M -$56.94 M -$30.82 M -$17.76 M -$4.20 M
Income Before Tax Ratio -1918.71 -1238.95 -8.18 -7.91 -4.93 -3.03 -0.7
Income Tax Expense $3,000.00 $4,000.00 $7,000.00 $15,000.00 $10,000.00 $1,000.00 $1,000.00
Net Income -$26.87 M -$27.26 M -$36.05 M -$56.96 M -$30.83 M -$17.77 M -$4.20 M
Net Income Ratio -1918.93 -1239.14 -8.18 -7.91 -4.93 -3.03 -0.7
EPS -25.98 -269.91 -1060.77 -5416.22 -4175.51 -1834.66 -433.96
EPS Diluted -25.98 -269.91 -1060.77 -5416.22 -4175.51 -1834.66 -433.96
Weighted Average Shares Out $1.03 M $101,000.00 $33,980.00 $10,516.00 $7,384.00 $9,683.00 $9,683.00
Weighted Average Shares Out Diluted $1.03 M $101,000.00 $33,980.00 $10,516.00 $7,384.00 $9,683.00 $9,683.00
Link